A total of 77 breast cancer tissues were eligible for analysis according to our previous inclusion criteria [17]; of these, 53 recurrent breast cancer specimens (33 local and 20 distant metastases) were identified as GPER+. The gene discussed is GPER1; the disease is breast carcinoma.